Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
- 1 May 1997
- journal article
- Published by Elsevier in Kidney International
- Vol. 51 (5) , 1583-1589
- https://doi.org/10.1038/ki.1997.217
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anti-DNA antibodies can bind to the glomerulus via two distinct mechanismsKidney International, 1992
- F(ab′)2 anti-CD4 and intact anti-CD4 monoclonal antibodies inhibit the accumulation of CD4+ T cells, CD8+ T cells, and B cells in the kidneys of lupus-prone NZB/NZW miceClinical Immunology and Immunopathology, 1990
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- Treatment of murine lupus nephritis with cyclophosphamide or total lymphoid irradiationKidney International, 1988
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Therapeutic studies in NZB/W MICEArthritis & Rheumatism, 1975
- Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in nzp/nzw miceArthritis & Rheumatism, 1973
- Therapeutic studies in NZB/W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combinationArthritis & Rheumatism, 1972
- CYCLOPHOSPHAMIDE TREATMENT OF RENAL DISEASE IN (NZB × NZW) F1 HYBRID MICEThe Lancet, 1968
- CYCLOPHOSPHAMIDE TREATMENT OF KIDNEY DISEASE IN (NZB X NZW) F1 MICEThe Lancet, 1966